| Product Code: ETC9560036 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Myasthenia Gravis Disease Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Myasthenia Gravis Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Myasthenia Gravis Disease Market - Industry Life Cycle |
3.4 Sweden Myasthenia Gravis Disease Market - Porter's Five Forces |
3.5 Sweden Myasthenia Gravis Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Sweden Myasthenia Gravis Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Sweden Myasthenia Gravis Disease Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Sweden Myasthenia Gravis Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 Sweden Myasthenia Gravis Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Myasthenia Gravis Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of myasthenia gravis in Sweden |
4.2.2 Advancements in treatment options and therapies for myasthenia gravis |
4.2.3 Growing research and development activities focused on finding new and improved treatments for myasthenia gravis |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing myasthenia gravis |
4.3.2 Limited availability of specialized healthcare professionals for myasthenia gravis management in Sweden |
5 Sweden Myasthenia Gravis Disease Market Trends |
6 Sweden Myasthenia Gravis Disease Market, By Types |
6.1 Sweden Myasthenia Gravis Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Edrophonium Test, 2021- 2031F |
6.1.4 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.1.5 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Repetitive Nerve Stimulation, 2021- 2031F |
6.1.6 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Single-fiber electromyography (EMG), 2021- 2031F |
6.1.7 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Myasthenia Gravis Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.4 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Immunosuppressants, 2021- 2031F |
6.2.5 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.2.6 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Autologous Hematopoietic Stem Cell Transplantation (HSCT), 2021- 2031F |
6.2.7 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 Sweden Myasthenia Gravis Disease Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Sweden Myasthenia Gravis Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Myasthenia Gravis Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Onlin Pharmacy, 2021- 2031F |
6.5.4 Sweden Myasthenia Gravis Disease Market Revenues & Volume, By Retail Phrmacy, 2021- 2031F |
7 Sweden Myasthenia Gravis Disease Market Import-Export Trade Statistics |
7.1 Sweden Myasthenia Gravis Disease Market Export to Major Countries |
7.2 Sweden Myasthenia Gravis Disease Market Imports from Major Countries |
8 Sweden Myasthenia Gravis Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for myasthenia gravis patients in Sweden |
8.2 Number of clinical trials for new myasthenia gravis treatments being conducted in Sweden |
8.3 Patient satisfaction with access to myasthenia gravis specialists in Sweden |
9 Sweden Myasthenia Gravis Disease Market - Opportunity Assessment |
9.1 Sweden Myasthenia Gravis Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Sweden Myasthenia Gravis Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Sweden Myasthenia Gravis Disease Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Sweden Myasthenia Gravis Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 Sweden Myasthenia Gravis Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Myasthenia Gravis Disease Market - Competitive Landscape |
10.1 Sweden Myasthenia Gravis Disease Market Revenue Share, By Companies, 2024 |
10.2 Sweden Myasthenia Gravis Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here